160 related articles for article (PubMed ID: 23143734)
1. PDE5 inhibition against acute renal ischemia reperfusion injury in rats: does vardenafil offer protection?
Kyriazis I; Kagadis GC; Kallidonis P; Georgiopoulos I; Marazioti A; Geronasiou A; Liourdi D; Loudos G; Schinas V; Apostolopoulos D; Papadaki H; Flordellis C; Nikiforidis GC; Papapetropoulos A; Liatsikos EN
World J Urol; 2013 Jun; 31(3):597-602. PubMed ID: 23143734
[TBL] [Abstract][Full Text] [Related]
2. Effects of vardenafil on the kidney of Wistar rats submitted to acute ischemia and reperfusion.
Sousa RC; Moreira Neto AA; Capelozzi VL; Ab'Saber AM; Rodrigues OR
Acta Cir Bras; 2015 May; 30(5):339-44. PubMed ID: 26016933
[TBL] [Abstract][Full Text] [Related]
3. Addition of vardenafil into storage solution protects the endothelium in a hypoxia-reoxygenation model.
Veres G; Hegedűs P; Barnucz E; Zöller R; Radovits T; Korkmaz S; Kolonics F; Weymann A; Karck M; Szabó G
Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):242-8. PubMed ID: 23751217
[TBL] [Abstract][Full Text] [Related]
4. PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.
Vignozzi L; Gacci M; Cellai I; Morelli A; Maneschi E; Comeglio P; Santi R; Filippi S; Sebastianelli A; Nesi G; Serni S; Carini M; Maggi M
Prostate; 2013 Sep; 73(13):1391-402. PubMed ID: 23765639
[TBL] [Abstract][Full Text] [Related]
5. Vardenafil improves penile erection in type 2 diabetes mellitus patients with erectile dysfunction: role of tropomyosin.
Zamorano-León JJ; Olivier C; de Las Heras N; Mateos-Cáceres PJ; Brime Menéndez R; Rodríguez-Sierra P; Martín Palacios N; Manso LS; Modrego J; Segura A; Macaya C; López-Farré AJ
J Sex Med; 2013 Dec; 10(12):3110-20. PubMed ID: 24112450
[TBL] [Abstract][Full Text] [Related]
6. Vardenafil reduces testicular damage following ischemia/reperfusion injury in rats.
Erol B; Tokgoz H; Hanci V; Bektas S; Akduman B; Yencilek F; Mungan G; Mungan A
Kaohsiung J Med Sci; 2009 Jul; 25(7):374-80. PubMed ID: 19605329
[TBL] [Abstract][Full Text] [Related]
7. Chronic vardenafil treatment improves erectile function via structural maintenance of penile corpora cavernosa in rats with acute arteriogenic erectile dysfunction.
Hotta Y; Hattori M; Kataoka T; Ohno R; Mikumo M; Maeda Y; Kimura K
J Sex Med; 2011 Mar; 8(3):705-11. PubMed ID: 21143425
[TBL] [Abstract][Full Text] [Related]
8. Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat: preliminary findings.
Fukuhara S; Tsujimura A; Okuda H; Yamamoto K; Takao T; Miyagawa Y; Nonomura N; Okuyama A
J Sex Med; 2011 Apr; 8(4):1061-71. PubMed ID: 21269399
[TBL] [Abstract][Full Text] [Related]
9. Targeting Phosphodiesterase-5 by Vardenafil Improves Vascular Graft Function.
Veres G; Hagenhoff M; Schmidt H; Radovits T; Loganathan S; Bai Y; Korkmaz-Icöz S; Brlecic P; Sayour AA; Karck M; Szabó G
Eur J Vasc Endovasc Surg; 2018 Aug; 56(2):256-263. PubMed ID: 29724533
[TBL] [Abstract][Full Text] [Related]
10. Vardenafil protects isolated rat hearts at reperfusion dependent on GC and PKG.
Maas O; Donat U; Frenzel M; Rütz T; Kroemer HK; Felix SB; Krieg T
Br J Pharmacol; 2008 May; 154(1):25-31. PubMed ID: 18332860
[TBL] [Abstract][Full Text] [Related]
11. Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats.
Morelli A; Filippi S; Sandner P; Fibbi B; Chavalmane AK; Silvestrini E; Sarchielli E; Vignozzi L; Gacci M; Carini M; Vannelli GB; Maggi M
J Sex Med; 2009 Jun; 6(6):1594-1608. PubMed ID: 19473460
[TBL] [Abstract][Full Text] [Related]
12. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
13. Vardenafil ameliorates immunologic- and non-immunologic-induced allergic reactions.
El-Awady MS; Said E
Can J Physiol Pharmacol; 2014 Mar; 92(3):175-80. PubMed ID: 24593781
[TBL] [Abstract][Full Text] [Related]
14. The effects of PDE5 inhibitory drugs on renal ischemia/reperfusion injury in rats.
Küçük A; Yucel M; Erkasap N; Tosun M; Koken T; Ozkurt M; Erkasap S
Mol Biol Rep; 2012 Oct; 39(10):9775-82. PubMed ID: 22736111
[TBL] [Abstract][Full Text] [Related]
15. Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass.
Szabó G; Radovits T; Veres G; Krieger N; Loganathan S; Sandner P; Karck M
Eur J Cardiothorac Surg; 2009 Oct; 36(4):657-64. PubMed ID: 19523842
[TBL] [Abstract][Full Text] [Related]
16. The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus.
Radovits T; Bömicke T; Kökény G; Arif R; Loganathan S; Kécsán K; Korkmaz S; Barnucz E; Sandner P; Karck M; Szabó G
Br J Pharmacol; 2009 Mar; 156(6):909-19. PubMed ID: 19298393
[TBL] [Abstract][Full Text] [Related]
17. Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: a proof of concept study for the treatment of phosphodiesterase type 5 inhibitor failure.
Oudot A; Behr-Roussel D; Poirier S; Sandner P; Bernabé J; Alexandre L; Giuliano F
Eur Urol; 2011 Nov; 60(5):1020-6. PubMed ID: 21839578
[TBL] [Abstract][Full Text] [Related]
18. Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
Toque HA; Priviero FB; Zemse SM; Antunes E; Teixeira CE; Webb RC
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):358-66. PubMed ID: 18986324
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits.
Salloum FN; Takenoshita Y; Ockaili RA; Daoud VP; Chou E; Yoshida K; Kukreja RC
J Mol Cell Cardiol; 2007 Feb; 42(2):453-8. PubMed ID: 17157308
[TBL] [Abstract][Full Text] [Related]
20. [Vardenafil (levitra): new aspects of clinical efficacy].
Gamidov SI; Iremashvili VV; Pavlovichev AA; Tazhetdinov OKh
Urologiia; 2010; (6):44-7. PubMed ID: 21427994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
